Titoli del Settore Sanitario
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 401 | ZURA Zura Bio Limited Class A Ordinary Shares | 5.69 USD | -0.52% | +0.35% | -8.37% | +399.12% | 539.87 M USD | ||
| 402 | TRDA Entrada Therapeutics, Inc. Common Stock | 13.9900 USD | -0.29% | -1.62% | +8.87% | +100.72% | 535.60 M USD | ||
| 403 | IMMX Immix Biopharma, Inc. Common Stock | 10.04 USD | +1.93% | +14.74% | -0.59% | +504.82% | 531.76 M USD | ||
| 404 | ALLO Allogene Therapeutics, Inc. Common Stock | 2.17 USD | -4.82% | -20.22% | -9.58% | +50.69% | 529.00 M USD | ||
| 405 | NPCE Neuropace, Inc. Common Stock | 15.6100 USD | +1.69% | +6.05% | +9.16% | +47.54% | 525.54 M USD | ||
| 406 | VALN Valneva SE American Depositary Shares | 6.03 USD | -0.99% | +1.86% | -41.74% | -12.74% | 523.22 M USD | ||
| 407 | ENGN enGene Therapeutics Inc. Common Stock | 7.7600 USD | +2.11% | +7.18% | +6.59% | -7.62% | 519.84 M USD | ||
| 408 | AQST Aquestive Therapeutics, Inc. Common Stock | 4.24 USD | +2.17% | +2.91% | +5.21% | +66.93% | 517.47 M USD | ||
| 409 | OFIX Orthofix Medical Inc. Common Stock (DE) | 12.8700 USD | +1.18% | +3.62% | +9.16% | -19.41% | 516.66 M USD | ||
| 410 | STTK Shattuck Labs, Inc. Common Stock | 7.17 USD | +5.75% | +2.14% | +19.50% | +774.39% | 513.12 M USD | ||
| 411 | FLGT Fulgent Genetics, Inc. Common Stock | 16.1700 USD | +0.94% | +2.21% | +8.82% | -31.57% | 505.00 M USD | ||
| 412 | LXEO Lexeo Therapeutics, Inc. Common Stock | 6.80 USD | +1.95% | +7.09% | +0.44% | +159.54% | 503.79 M USD | ||
| 413 | LRMR Larimar Therapeutics, Inc. Common Stock | 4.83 USD | -0.82% | -5.11% | +2.99% | +161.08% | 501.75 M USD | ||
| 414 | CATX Perspective Therapeutics, Inc. | 4.39 USD | +3.54% | +1.39% | -12.72% | +110.05% | 500.17 M USD | ||
| 415 | FDMT 4D Molecular Therapeutics, Inc. Common Stock | 9.7700 USD | +1.14% | -2.30% | +15.76% | -13.54% | 498.77 M USD | ||
| 416 | VREX Varex Imaging Corporation Common Stock | 11.78 USD | +0.34% | +7.09% | +6.80% | +54.39% | 493.58 M USD | ||
| 417 | STRO Sutro Biopharma, Inc. | 29.7700 USD | +3.44% | +9.85% | +28.76% | +71.19% | 493.21 M USD | ||
| 418 | KMDA Kamada Ltd | 8.44 USD | +0.24% | +1.20% | -3.87% | +32.08% | 486.87 M USD | ||
| 419 | MYGN Myriad Genetics Inc | 5.1900 USD | +5.70% | +9.49% | +11.37% | -37.24% | 485.31 M USD | ||
| 420 | ABSI Absci Corporation Common Stock | 3.17 USD | +0.63% | +7.46% | +30.45% | +2.26% | 485.08 M USD |
Notizie Titoli del Settore Sanitario
VFLO: Free Cash Flow + Growth Is A Winning Formula (NASDAQ:VFLO)
Jefferies conferma Buy su BridgeBio Pharma, target $100
BofA alza il target su Hims and Hers per opzionalità sui peptidi
Universal Health Services Is A Huge Bargain At 8x Earnings Vs HCA At 16x (NYSE:UHS)
BofA alza il target su Ascendis Pharma per le vendite di Yorvipath
Precision BioSciences, Inc. (DTIL) Presents at 25th Annual Needham Virtual Healthcare Conference Transcript
Humana dichiara un dividendo trimestrale di 0,885 dollari per azione
Gainers Titoli del Settore Sanitario
IMMP Immutep Limited American Depositary Shares | 0.54 | +74.19% |
CUE Cue Biopharma, Inc. | 0.72 | +63.64% |
NOTV Inotiv, Inc. Common Stock | 0.39 | +56.00% |
NIVFW NewGenIvf Group Limited Class A ordinary shares | 0.0194 | +45.86% |
CDTTW CDT Equity Inc. Common Stock | 0.0085 | +41.67% |
NXGL NexGel, Inc Common Stock | 0.76 | +28.81% |
PDSB PDS Biotechnology Corporation Common Stock | 1.36 | +28.30% |
TSHA Taysha Gene Therapies, Inc. Common Stock | 6.00 | +27.39% |
Losers Titoli del Settore Sanitario
WORX SC WORX Corp | 1.06 | -30.72% |
CMND Clearmind Medicine Inc. Common Shares | 0.65 | -28.57% |
BEAT Heartbeam, Inc. Common Stock | 0.89 | -25.83% |
TALKW Talkspace, Inc. Common Stock | 0.0016 | -23.81% |
CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.0796 | -20.32% |
JSPRW Jasper Therapeutics, Inc. Common Stock | 0.0166 | -20.19% |
TOIIW The Oncology Institute, Inc. Common Stock | 0.0399 | -18.40% |
ONCO Onconetix, Inc. Common Stock | 0.7615 | -16.32% |